Internet Archive Scholar

TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock

B. Daubeuf, J. Mathison, S. Spiller, S. Hugues, S. Herren, W. Ferlin, M. Kosco-Vilbois, H. Wagner, C. J. Kirschning, R. Ulevitch, G. Elson
2007 Journal of Immunology  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (819.8 kB)
https://web.archive.org/web/20190502000010/http://www.jimmunol.org/content/jimmunol/179/9/6107.full.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

doi:10.4049/jimmunol.179.9.6107 pmid:17947685 fatcat:sfxctokt4ndupp63bej5dxnj2y
Citation

B. Daubeuf, J. Mathison, S. Spiller, S. Hugues, S. Herren, W. Ferlin, M. Kosco-Vilbois, H. Wagner, C. J. Kirschning, R. Ulevitch, G. Elson. "TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock." Journal of Immunology 179.9 (2007) 6107-6114